JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

961.85 1.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

937.61

Max

965.92

Schlüsselkennzahlen

By Trading Economics

Einkommen

426M

1.2B

Verkäufe

5.3B

103B

KGV

Branchendurchschnitt

26.453

84.243

Dividendenrendite

0.35

Gewinnspanne

1.173

Angestellte

43,000

EBITDA

212M

1.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1.28% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.28%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.3B

105B

Vorheriger Eröffnungskurs

960.04

Vorheriger Schlusskurs

961.85

Nachrichtenstimmung

By Acuity

36%

64%

99 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Feb. 2026, 17:25 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9. Feb. 2026, 23:43 UTC

Market Talk

Gold Falls on Possible Technical Correction -- Market Talk

9. Feb. 2026, 23:14 UTC

Market Talk

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9. Feb. 2026, 22:29 UTC

Market Talk

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9. Feb. 2026, 22:19 UTC

Market Talk

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9. Feb. 2026, 22:08 UTC

Market Talk

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9. Feb. 2026, 22:01 UTC

Ergebnisse

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9. Feb. 2026, 21:59 UTC

Ergebnisse

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9. Feb. 2026, 21:59 UTC

Ergebnisse

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9. Feb. 2026, 21:58 UTC

Ergebnisse

Friedman Industries 3Q Sales $168M >FRD

9. Feb. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

9. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Feb. 2026, 21:48 UTC

Ergebnisse

Friedman Industries 3Q EPS 43c >FRD

9. Feb. 2026, 21:17 UTC

Ergebnisse

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9. Feb. 2026, 21:13 UTC

Market Talk

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9. Feb. 2026, 21:04 UTC

Ergebnisse

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9. Feb. 2026, 20:30 UTC

Market Talk

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9. Feb. 2026, 20:02 UTC

Market Talk

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9. Feb. 2026, 19:42 UTC

Market Talk

Japan's Yield Curve Expected to Flatten -- Market Talk

9. Feb. 2026, 19:31 UTC

Market Talk

Nike Seen Regaining Relevance With Consumers -- Market Talk

9. Feb. 2026, 19:27 UTC

Market Talk

Gold Climbs Back Over $5,000/oz -- Market Talk

9. Feb. 2026, 19:05 UTC

Market Talk

Nike Returns to List of Hottest Brands -- Market Talk

9. Feb. 2026, 18:19 UTC

Market Talk

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9. Feb. 2026, 17:41 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9. Feb. 2026, 17:31 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9. Feb. 2026, 17:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

9. Feb. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Feb. 2026, 17:17 UTC

Market Talk

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9. Feb. 2026, 17:16 UTC

Ergebnisse

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

1.28% Vorteil

12-Monats-Prognose

Durchschnitt 960.8 USD  1.28%

Hoch 1,012 USD

Tief 885 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

8

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

99 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat